#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
AAC_3__IV.3002539.DQ241380.1.0_777.3715	AAC_3__IV.3002539.DQ241380.1.0_777.3715	1	0	27	392	AAC_3__IV	777	777	100.0	AAC_3__IV.l6.c30.ctg.1	1239	16.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AAC(3)-IV is a plasmid-encoded aminoglycoside acetyltransferase in E. coli, C. jejuni and P. stutzeri;AAC(3)-IV
ANT_2____Ia.3000230.X04555.0_750.458	ANT_2____Ia.3000230.X04555.0_750.458	1	0	16	120	ANT_2____Ia	750	211	100.0	ANT_2____Ia.l6.c30.ctg.1	617	10.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Plasmid or integron-encoded nucleotidylylation of 2-deoxystreptamine aminoglycosides at the hydroxyl group at position 2'' in P. aeruginosa, K. pneumoniae, Morganella morganii, E. coli, S. typhimurium, C. freundii and A. baumannii;ANT(2'')-Ia
APH_3___Ia.3002641.BX664015.103017_103833.279	APH_3___Ia.3002641.BX664015.103017_103833.279	1	0	539	306	APH_3___Ia	816	816	99.39	APH_3___Ia.l15.c4.ctg.1	1189	13.7	0	.	p	.	0	L19M	NONSYN	55	57	CTG	210	212	ATG	16;16;15	A;T;G	16;16;15	.	APH(3')-Ia;APH(3')-Ia is a transposon-encoded aminoglycoside phosphotransferase in E. coli and S. enterica. It is identical at the protein sequence to APH(3')-Ic, an aminoglycoside phosphotransferase encoded by plasmids, transposons and genomic islands in K. pneumoniae, A. baumannii, S. marcescens, Corynebacterium spp., Photobacterium spp. and Citrobacter spp.
APH_3___Ia.3002641.BX664015.103017_103833.279	APH_3___Ia.3002641.BX664015.103017_103833.279	1	0	539	306	APH_3___Ia	816	816	99.39	APH_3___Ia.l15.c4.ctg.1	1189	13.7	0	.	p	.	0	R27K	NONSYN	79	81	AGA	234	236	AAA	10;11;12	A;A;A	10;11;12	.	APH(3')-Ia;APH(3')-Ia is a transposon-encoded aminoglycoside phosphotransferase in E. coli and S. enterica. It is identical at the protein sequence to APH(3')-Ic, an aminoglycoside phosphotransferase encoded by plasmids, transposons and genomic islands in K. pneumoniae, A. baumannii, S. marcescens, Corynebacterium spp., Photobacterium spp. and Citrobacter spp.
APH_3___Ia.3002641.BX664015.103017_103833.279	APH_3___Ia.3002641.BX664015.103017_103833.279	1	0	539	306	APH_3___Ia	816	816	99.39	APH_3___Ia.l15.c4.ctg.1	1189	13.7	0	.	p	.	0	N48D	NONSYN	142	144	AAT	297	299	GAT	12;12;12	G;A;T	12;11;11	.	APH(3')-Ia;APH(3')-Ia is a transposon-encoded aminoglycoside phosphotransferase in E. coli and S. enterica. It is identical at the protein sequence to APH(3')-Ic, an aminoglycoside phosphotransferase encoded by plasmids, transposons and genomic islands in K. pneumoniae, A. baumannii, S. marcescens, Corynebacterium spp., Photobacterium spp. and Citrobacter spp.
APH_3___Ia.3002641.BX664015.103017_103833.279	APH_3___Ia.3002641.BX664015.103017_103833.279	1	0	539	306	APH_3___Ia	816	816	99.39	APH_3___Ia.l15.c4.ctg.1	1189	13.7	0	.	p	.	0	A77E	NONSYN	229	231	GCA	384	386	GAA	6;7;7	G;A;A	5;7;7	.	APH(3')-Ia;APH(3')-Ia is a transposon-encoded aminoglycoside phosphotransferase in E. coli and S. enterica. It is identical at the protein sequence to APH(3')-Ic, an aminoglycoside phosphotransferase encoded by plasmids, transposons and genomic islands in K. pneumoniae, A. baumannii, S. marcescens, Corynebacterium spp., Photobacterium spp. and Citrobacter spp.
APH_4__Ia.3002655.V01499.230_1256.221	APH_4__Ia.3002655.V01499.230_1256.221	1	0	27	388	APH_4__Ia	1026	1026	100.0	APH_4__Ia.l6.c17.ctg.1	1518	13.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	APH(4)-Ia;APH(4)-Ia is a plasmid-encoded aminoglycoside phosphotransferase in E. coli
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	772	CRP	633	633	99.53	CRP.l15.c30.ctg.1	1217	34.0	0	.	p	.	0	K29T	NONSYN	85	87	AAG	365	367	ACG	43;42;42	A;C;G	43;42;42	.	CRP is a global regulator that represses MdtEF multidrug efflux pump expression.;CRP
Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	1	1	167	2372	Escherichia_coli_EF_Tu	1185	1165	99.74	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1165	91.6	0	HET	.	.	.	C954T	.	954	954	C	953	953	C	103	C,T	58,45	.	Escherichia coli EF-Tu mutants conferring resistance to Enacyloxin IIa
Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	1	1	167	2372	Escherichia_coli_EF_Tu	1185	1165	99.74	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1165	91.6	0	HET	.	.	.	T135C	.	135	135	T	134	134	T	67	T,C	46,17	.	Escherichia coli EF-Tu mutants conferring resistance to Enacyloxin IIa
Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	1	1	167	2372	Escherichia_coli_EF_Tu	1185	1165	99.74	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1165	91.6	0	HET	.	.	.	C216T	.	216	216	C	215	215	C	66	C,T	41,24	.	Escherichia coli EF-Tu mutants conferring resistance to Enacyloxin IIa
Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	1	1	167	2372	Escherichia_coli_EF_Tu	1185	69	100.0	Escherichia_coli_EF_Tu.l15.c17.ctg.3	190	18.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli EF-Tu mutants conferring resistance to Enacyloxin IIa
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	1106	Escherichia_coli_mutant_1	1359	1359	99.85	Escherichia_coli_mutant_1.l15.c30.ctg.1	1865	31.7	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1586	1588	AAA	15;17;16	A;A;A	15;17;16	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	1346	Escherichia_coli_mutant	1392	1392	99.43	Escherichia_coli_mutant.l6.c30.ctg.1	1983	36.3	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1376	1378	GAA	43;42;41	G;A;A	43;42;41	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	296	H_NS	414	414	99.03	H_NS.l15.c30.ctg.1	895	17.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.;H-NS
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3882	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	518	152.8	0	.	n	.	0	A1136G	SNP	1136	1136	A	96	96	G	150	G	148	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3882	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	518	152.8	0	.	n	.	0	T1138C	SNP	1138	1138	T	98	98	C	132	C	128	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3882	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	518	152.8	0	.	n	.	0	T1142C	SNP	1142	1142	T	102	102	C	122	C	119	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3882	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	518	152.8	0	.	n	.	0	C1170T	SNP	1170	1170	C	130	130	T	156	T	155	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3882	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	518	152.8	0	.	n	.	0	T1220C	SNP	1220	1220	T	180	180	C	168	C	168	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3882	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	518	152.8	0	.	n	.	0	T1245C	SNP	1245	1245	T	205	205	C	124	C,T	122,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3882	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	518	152.8	0	.	n	.	0	G1253A	SNP	1253	1253	G	213	213	A	126	A,G	125,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3882	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	518	152.8	0	.	n	.	0	G1256A	SNP	1256	1256	G	216	216	A	125	A	125	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3882	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	518	152.8	0	.	n	.	0	C1258A	SNP	1258	1258	C	218	218	A	123	A	122	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3882	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	518	152.8	0	.	n	.	0	G1266T	SNP	1266	1266	G	226	226	T	120	T	117	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3882	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	518	152.8	0	.	n	.	0	T1267C	SNP	1267	1267	T	227	227	C	119	C	116	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3882	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	518	152.8	0	.	n	.	0	T1275C	SNP	1275	1275	T	235	235	C	114	C	114	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3882	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	518	152.8	0	.	n	.	0	G1276A	SNP	1276	1276	G	236	236	A	112	A	112	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3882	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	518	152.8	0	.	n	.	0	A1281G	SNP	1281	1281	A	241	241	G	105	G,T	104,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3882	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	518	152.8	0	.	n	.	0	T1283C	SNP	1283	1283	T	243	243	C	104	C	102	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3882	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	518	152.8	0	.	n	.	0	G1288T	SNP	1288	1288	G	248	248	T	102	T	102	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3882	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	518	152.8	0	.	n	.	0	A1296G	SNP	1296	1296	A	256	256	G	132	G	131	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3882	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	518	152.8	0	.	n	.	0	T1299G	SNP	1299	1299	T	259	259	G	150	G	149	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3882	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	518	152.8	0	.	n	.	0	A1300T	SNP	1300	1300	A	260	260	T	155	T	155	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3882	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	518	152.8	0	.	n	.	0	C1356T	SNP	1356	1356	C	316	316	T	177	T	177	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3882	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	518	152.8	0	.	n	.	0	A1358G	SNP	1358	1358	A	318	318	G	158	G	158	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3882	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	518	152.8	0	.	n	.	0	T1368C	SNP	1368	1368	T	328	328	C	131	C	129	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3882	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	518	152.8	0	.	n	.	0	G1370A	SNP	1370	1370	G	330	330	A	120	A	120	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3882	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	518	152.8	0	.	n	.	0	C1406.	DEL	1406	1406	C	365	365	C	120	C	120	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3882	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	518	152.8	0	.	n	.	0	.1409C	INS	1409	1409	T	369	369	C	120	C	119	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3882	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	518	152.8	0	.	n	.	0	C1431A	SNP	1431	1431	C	391	391	A	68	A	68	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3882	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	518	152.8	0	.	n	.	0	C1432A	SNP	1432	1432	C	392	392	A	67	A	67	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3882	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	518	152.8	0	.	n	.	0	A1441G	SNP	1441	1441	A	401	401	G	62	G	61	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3882	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	518	152.8	0	.	n	.	0	T1464C	SNP	1464	1464	T	424	424	C	50	C	50	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3882	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	518	152.8	0	.	n	.	0	G1473T	SNP	1473	1473	G	433	433	T	106	T	106	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3882	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	518	152.8	0	.	n	.	0	A1475G	SNP	1475	1475	A	435	435	G	112	G	112	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3882	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	518	152.8	0	.	n	.	0	A1548T	SNP	1548	1548	A	508	508	T	53	T	53	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3882	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.1	518	152.8	1	SNP	n	C1194G	0	.	.	1194	1194	C	154	154	C	196	C	194	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252:0:0:C1194G:.:Point mutations in the helix 34 region of 16S rRNA of Pasteurella multocida can confer resistance to spectinomycin	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3882	Pasteurella_multocida_16S	1551	143	90.91	Pasteurella_multocida_16S.l15.c17.ctg.6	143	60.4	0	.	n	.	0	C990G	SNP	990	990	C	40	40	G	55	G	43	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3882	Pasteurella_multocida_16S	1551	143	90.91	Pasteurella_multocida_16S.l15.c17.ctg.6	143	60.4	0	.	n	.	0	T1002A	SNP	1002	1002	T	52	52	A	54	A	54	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3882	Pasteurella_multocida_16S	1551	143	90.91	Pasteurella_multocida_16S.l15.c17.ctg.6	143	60.4	0	.	n	.	0	A1004G	SNP	1004	1004	A	54	54	G	55	G,A	50,5	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3882	Pasteurella_multocida_16S	1551	143	90.91	Pasteurella_multocida_16S.l15.c17.ctg.6	143	60.4	0	.	n	.	0	C1011T	SNP	1011	1011	C	61	61	T	52	T	52	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3882	Pasteurella_multocida_16S	1551	143	90.91	Pasteurella_multocida_16S.l15.c17.ctg.6	143	60.4	0	.	n	.	0	C1023A	SNP	1023	1023	C	73	73	A	56	A	55	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3882	Pasteurella_multocida_16S	1551	143	90.91	Pasteurella_multocida_16S.l15.c17.ctg.6	143	60.4	0	.	n	.	0	T1024A	SNP	1024	1024	T	74	74	A	56	A	55	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3882	Pasteurella_multocida_16S	1551	143	90.91	Pasteurella_multocida_16S.l15.c17.ctg.6	143	60.4	0	.	n	.	0	T1041G	SNP	1041	1041	T	91	91	G	72	G	72	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3882	Pasteurella_multocida_16S	1551	143	90.91	Pasteurella_multocida_16S.l15.c17.ctg.6	143	60.4	0	.	n	.	0	A1042T	SNP	1042	1042	A	92	92	T	71	T	71	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1068	PmrB_1	1092	1092	99.08	PmrB_1.l15.c4.ctg.1	1576	36.4	0	.	p	.	0	H2R	NONSYN	4	6	CAT	284	286	CGT	36;38;38	C;G;T	35;37;38	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1068	PmrB_1	1092	1092	99.08	PmrB_1.l15.c4.ctg.1	1576	36.4	0	.	p	.	0	V30I	NONSYN	88	90	GTC	368	370	ATC	53;53;52	A;T;C	52;52;52	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1068	PmrB_1	1092	1092	99.08	PmrB_1.l15.c4.ctg.1	1576	36.4	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1127	1129	GGC	51;52;55	G;G;C	50;52;54	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1522	PmrC	1644	1644	99.15	PmrC.l6.c30.ctg.1	2196	37.1	0	.	p	.	0	R8S	NONSYN	22	24	AGA	372	374	AGC	25;26;25	A;G;C	24;25;25	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1522	PmrC	1644	1644	99.15	PmrC.l6.c30.ctg.1	2196	37.1	0	.	p	.	0	I142L	NONSYN	424	426	ATA	774	776	CTA	49;49;48	C;T;A	49;49;48	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1522	PmrC	1644	1644	99.15	PmrC.l6.c30.ctg.1	2196	37.1	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1293	1295	CAA	36;39;40	C;A;A	36;39;39	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1522	PmrC	1644	1644	99.15	PmrC.l6.c30.ctg.1	2196	37.1	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1392	1394	GGT	40;41;40	G;G;T	40;41;40	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1522	PmrC	1644	1644	99.15	PmrC.l6.c30.ctg.1	2196	37.1	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1962	1964	GTT	28;26;23	G;T;T	28;26;23	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	598	PmrE	1167	1167	96.83	PmrE.l6.c17.ctg.1	1641	19.5	0	.	p	.	0	A125E	NONSYN	373	375	GCA	591	593	GAA	18;19;20	G;A;A	18;19;20	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	598	PmrE	1167	1167	96.83	PmrE.l6.c17.ctg.1	1641	19.5	0	.	p	.	0	M185T	NONSYN	553	555	ATG	771	773	ACC	11;11;10	A;C;C	11;11;10	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	598	PmrE	1167	1167	96.83	PmrE.l6.c17.ctg.1	1641	19.5	0	.	p	.	0	S225T	NONSYN	673	675	TCC	891	893	ACT	12;13;14	A;C;T	12;13;14	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	598	PmrE	1167	1167	96.83	PmrE.l6.c17.ctg.1	1641	19.5	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	1281	1283	ATC	16;16;16	A;T,G;C	16;15,1;16	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	27	762	PmrF	969	969	99.38	PmrF.l15.c30.ctg.1	1421	28.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrF
aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	1	0	161	1368	aad-	789	591	100.0	aad-.l15.c30.ctg.1	661	59.2	0	HET	.	.	.	T540C	.	540	540	T	610	610	T	62	T,C	54,7	.	Original ref seq: NC_007384.1 Shigella sonnei Ss046, complete genome
aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	1	0	161	1368	aad-	789	591	100.0	aad-.l15.c30.ctg.1	661	59.2	0	HET	.	.	.	A510G	.	510	510	A	580	580	A	69	A,G	60,9	.	Original ref seq: NC_007384.1 Shigella sonnei Ss046, complete genome
aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	1	0	161	1368	aad-	789	591	100.0	aad-.l15.c30.ctg.1	661	59.2	0	HET	.	.	.	A498G	.	498	498	A	568	568	A	64	A,G	54,10	.	Original ref seq: NC_007384.1 Shigella sonnei Ss046, complete genome
aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	1	0	161	1368	aad-	789	591	100.0	aad-.l15.c30.ctg.1	661	59.2	0	HET	.	.	.	C512A	.	512	512	C	582	582	C	71	C,A	62,9	.	Original ref seq: NC_007384.1 Shigella sonnei Ss046, complete genome
aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	1	0	161	1368	aad-	789	591	100.0	aad-.l15.c30.ctg.1	661	59.2	0	HET	.	.	.	A357G	.	357	357	A	427	427	A	66	A,G	52,11	.	Original ref seq: NC_007384.1 Shigella sonnei Ss046, complete genome
aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	1	0	161	1368	aad-	789	591	100.0	aad-.l15.c30.ctg.1	661	59.2	0	HET	.	.	.	C457T	.	457	457	C	527	527	C	56	C,T	45,11	.	Original ref seq: NC_007384.1 Shigella sonnei Ss046, complete genome
aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	1	0	161	1368	aad-	789	591	100.0	aad-.l15.c30.ctg.1	661	59.2	0	HET	.	.	.	G393A,T	.	393	393	G	463	463	G	67	G,A,T	54,12,1	.	Original ref seq: NC_007384.1 Shigella sonnei Ss046, complete genome
aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	1	0	161	1368	aad-	789	591	100.0	aad-.l15.c30.ctg.1	661	59.2	0	HET	.	.	.	T489C	.	489	489	T	559	559	T	61	T,C	49,12	.	Original ref seq: NC_007384.1 Shigella sonnei Ss046, complete genome
aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	1	0	161	1368	aad-	789	591	100.0	aad-.l15.c30.ctg.1	661	59.2	0	HET	.	.	.	T501G	.	501	501	T	571	571	T	65	T,G	55,10	.	Original ref seq: NC_007384.1 Shigella sonnei Ss046, complete genome
aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	1	0	161	1368	aad-	789	591	100.0	aad-.l15.c30.ctg.1	661	59.2	0	HET	.	.	.	T400C	.	400	400	T	470	470	T	73	T,C	57,16	.	Original ref seq: NC_007384.1 Shigella sonnei Ss046, complete genome
aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	1	0	161	1368	aad-	789	591	100.0	aad-.l15.c30.ctg.1	661	59.2	0	HET	.	.	.	T465C	.	465	465	T	535	535	T	56	T,C	45,10	.	Original ref seq: NC_007384.1 Shigella sonnei Ss046, complete genome
aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	1	0	161	1368	aad-	789	591	100.0	aad-.l15.c30.ctg.1	661	59.2	0	HET	.	.	.	A306G	.	306	306	A	376	376	A	62	A,G	53,9	.	Original ref seq: NC_007384.1 Shigella sonnei Ss046, complete genome
aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	1	0	161	1368	aad-	789	591	100.0	aad-.l15.c30.ctg.1	661	59.2	0	HET	.	.	.	A500G	.	500	500	A	570	570	A	65	A,G	55,10	.	Original ref seq: NC_007384.1 Shigella sonnei Ss046, complete genome
aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	1	0	161	1368	aad-	789	591	100.0	aad-.l15.c30.ctg.1	661	59.2	0	HET	.	.	.	G405T	.	405	405	G	475	475	G	71	G,T	54,17	.	Original ref seq: NC_007384.1 Shigella sonnei Ss046, complete genome
aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	1	0	161	1368	aad-	789	161	100.0	aad-.l15.c30.ctg.4	161	48.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_007384.1 Shigella sonnei Ss046, complete genome
acrB.3000216.DQ679966.1515_4662.624	acrB.3000216.DQ679966.1515_4662.624	1	0	16	38	acrB	3147	143	90.91	acrB.l6.c4.ctg.2	146	6.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Protein subunit of AcrA-AcrB-TolC multidrug efflux complex. AcrB functions as a herterotrimer which forms the inner membrane component and is primarily responsible for substrate recognition and energy transduction by acting as a drug/proton antiporter.;acrB
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	2306	acrD	3114	3114	99.1	acrD.l15.c30.ctg.1	3685	33.5	0	.	p	.	0	T85I	NONSYN	253	255	ACC	559	561	ATC	38;38;36	A;T;C	38;38;36	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	2306	acrD	3114	3114	99.1	acrD.l15.c30.ctg.1	3685	33.5	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2272	2274	AAG	27;29;28	A;A;G,T	26;29;27,1	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	970	acrE	1158	1158	98.79	acrE.l15.c30.ctg.1	1670	31.0	0	.	p	.	0	A22V	NONSYN	64	66	GCC	316	318	GTC	19;19;19	G;T;C	19;19;19	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	970	acrE	1158	1158	98.79	acrE.l15.c30.ctg.1	1670	31.0	0	.	p	.	0	S269C	NONSYN	805	807	AGC	1057	1059	TGC	48;48;49	T;G;C	47;47;49	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	2286	acrF	3105	2598	98.5	acrF.l6.c4.ctg.1	3093	39.5	0	.	p	.	0	S46trunc	TRUNC	136	136	T	333	333	T	30	T	30	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	2286	acrF	3105	2598	98.5	acrF.l6.c4.ctg.1	3093	39.5	0	.	p	.	0	G148D	NONSYN	442	444	GGC	639	641	GAC	47;46;46	G;A;C	47;46;45	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	2286	acrF	3105	2598	98.5	acrF.l6.c4.ctg.1	3093	39.5	0	.	p	.	0	F240L	NONSYN	718	720	TTT	915	917	TTA	28;28;27	T;T;A	28;28;27	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	2286	acrF	3105	2598	98.5	acrF.l6.c4.ctg.1	3093	39.5	0	.	p	.	0	D301N	NONSYN	901	903	GAT	1098	1100	AAT	29;30;31	A;A;T	27;29;29	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	2286	acrF	3105	2598	98.5	acrF.l6.c4.ctg.1	3093	39.5	0	.	p	.	0	L563fs	FSHIFT	1687	1687	T	1885	1885	T	51	T	51	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	634	acrR_2	648	648	99.54	acrR_2.l15.c30.ctg.1	1259	26.8	1	SNP	p	R45C	0	.	.	133	135	CGC	465	467	CGC	47;46;45	C;G;C	47;46;45	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	594	acrS	663	663	98.64	acrS.l15.c4.ctg.1	1043	30.4	0	.	p	.	0	L34F	NONSYN	100	102	CTC	303	305	TTC	20;20;19	T;T;C	20;20;19	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	594	acrS	663	663	98.64	acrS.l15.c4.ctg.1	1043	30.4	0	.	p	.	0	E122G	NONSYN	364	366	GAG	567	569	GGG	45;45;46	G;G;G	45;45;45	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	836	adiY	762	762	99.61	adiY.l15.c30.ctg.1	1204	36.8	0	.	p	.	0	V136L	NONSYN	406	408	GTT	609	611	CTT	41;42;43	C;T;T	41;42;43	.	adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.;adiY
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2114	alaS	2631	2631	98.86	alaS.l15.c30.ctg.1	3185	35.6	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2124	2126	GCA	41;41;43	G;C;A	41;40;43	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2114	alaS	2631	2631	98.86	alaS.l15.c30.ctg.1	3185	35.6	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2385	2387	ACC	34;34;34	A;C;C	33;33;33	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2114	alaS	2631	2631	98.86	alaS.l15.c30.ctg.1	3185	35.6	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2694	2696	GCC	35;35;37	G;C;C	35;35;37	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1230	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2456	26.8	0	.	p	.	0	G37A	NONSYN	109	111	GGT	304	306	GCT	10;10;12	G;C;T	10;10;12	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1230	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2456	26.8	0	.	p	.	0	D77E	NONSYN	229	231	GAT	424	426	GAG	14;15;16	G;A;G	14;15;16	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1230	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2456	26.8	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	460	462	TGC	20;19;18	T;G;C	20;19;18	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1230	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2456	26.8	0	.	p	.	0	I150V	NONSYN	448	450	ATT	643	645	GTT	23;24;24	G;T;T	23;24;24	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1230	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2456	26.8	0	.	p	.	0	R200H	NONSYN	598	600	CGC	793	795	CAC	30;29;29	C;A;C	30;29;29	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1230	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2456	26.8	0	.	p	.	0	T295M	NONSYN	883	885	ACG	1078	1080	ATG	38;38;40	A;T;G	38;37;39	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1230	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2456	26.8	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	2074	2076	CGC	25;24;26	C;G;C	25;24;26	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	692	bacA	822	822	98.54	bacA.l15.c4.ctg.1	1226	29.7	0	.	p	.	0	S221T	NONSYN	661	663	AGC	952	954	ACC	26;26;27	A;C;C	26;26;27	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	692	bacA	822	822	98.54	bacA.l15.c4.ctg.1	1226	29.7	0	.	p	.	0	P225S	NONSYN	673	675	CCG	964	966	TCG	31;33;32	T;C;G	31;32;32	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	27	514	baeR	723	723	97.79	baeR.l15.c30.ctg.1	1115	24.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	baeR;BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	932	baeS	1404	1404	98.86	baeS.l15.c17.ctg.1	1954	25.5	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1419	1421	AAA	8;8;9	A;A;A	8;8;9	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	932	baeS	1404	1404	98.86	baeS.l15.c17.ctg.1	1954	25.5	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1431	1433	GAG	11;10;12	G;A;G	11;10;12	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	932	baeS	1404	1404	98.86	baeS.l15.c17.ctg.1	1954	25.5	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1437	1439	CAC	15;15;15	C;A;C	15;15;15	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	932	baeS	1404	1404	98.86	baeS.l15.c17.ctg.1	1954	25.5	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1491	1493	GAG	16;16;17	G;A;G,T	16;16;16,1	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	27	1210	cpxA	1374	1374	98.91	cpxA.l15.c4.ctg.1	1929	33.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxA;CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	746	cpxR	699	699	99.43	cpxR.l6.c30.ctg.1	1302	30.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxR;CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	539	774	cysB	975	975	99.28	cysB.l6.c4.ctg.1	1452	28.5	0	.	p	.	0	A146T	NONSYN	436	438	GCT	651	653	ACT	37;36;35	A;C;T	37;36;35	.	aminocoumarin resistant cysB;Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.
dfrA1.3002854.NC_010410.3676915_3677389.140	dfrA1.3002854.NC_010410.3676915_3677389.140	1	0	27	550	dfrA1_1	474	474	100.0	dfrA1_1.l6.c30.ctg.1	902	31.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	dfrA1 is an integron-encoded dihydrofolate reductase found in Escherichia coli;dfrA1
dfrA12.manually_added_Z21672_CAA79767.1_310_807	dfrA12.manually_added_Z21672_CAA79767.1_310_807	1	0	27	262	dfrA12	498	498	100.0	dfrA12.l6.c30.ctg.1	941	14.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: Z21672.1 E.coli dhfrXII gene encoding dihydrofolate reductase
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	928	emrA	1173	1173	98.29	emrA.l15.c30.ctg.1	1708	29.0	0	.	p	.	0	I219V	NONSYN	655	657	ATC	899	901	GTC	43;44;44	G,T;T;C	41,1;42;43	.	EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.;emrA
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	539	1344	emrB	1539	1539	99.74	emrB.l15.c30.ctg.1	2127	33.8	0	.	p	.	0	E197K	NONSYN	589	591	GAA	901	903	AAA	45;45;45	A;A;A	45;43;44	.	emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.;emrB
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	1006	emrD	1191	1191	98.4	emrD.l15.c4.ctg.1	1655	32.5	0	.	p	.	0	G209S	NONSYN	625	627	GGC	857	859	AGC	45;46;45	A;G;C	44;45;44	.	emrD;EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	16	38	emrE_1	333	89	96.63	emrE_1.l15.c4.ctg.1	89	10.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrE;EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	824	emrK	1056	1056	98.2	emrK.l15.c30.ctg.1	1634	27.0	0	.	p	.	0	K176R	NONSYN	526	528	AAG	809	811	AGG	33;33;32	A;G;G	33;32;32	.	emrK;emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	824	emrK	1056	1056	98.2	emrK.l15.c30.ctg.1	1634	27.0	0	.	p	.	0	N306D	NONSYN	916	918	AAC	1199	1201	GAC	32;32;32	G;A,C;C	32;31,1;32	.	emrK;emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	554	emrR	531	531	100.0	emrR.l15.c30.ctg.1	1122	26.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrR;EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	1262	emrY	1539	1539	99.81	emrY.l15.c30.ctg.1	2136	31.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY;emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	568	evgA	615	615	99.19	evgA.l15.c30.ctg.1	1211	25.2	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	512	514	CTG	38;38;38	C;T;G	38;38;38	.	evgA;EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2372	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4148	30.6	0	.	p	.	0	T38I	NONSYN	112	114	ACA	400	402	ATA	30;29;29	A;T;A	30;29;29	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2372	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4148	30.6	0	.	p	.	0	L42V	NONSYN	124	126	CTA	412	414	GTA	22;22;24	G;T;A	22;22;24	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2372	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4148	30.6	0	.	p	.	0	A93T	NONSYN	277	279	GCG	565	567	ACG	19;20;22	A;C;G	19;20;22	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2372	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4148	30.6	0	.	p	.	0	A114E	NONSYN	340	342	GCA	628	630	GAA	17;17;17	G;A;A	17;17;17	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2372	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4148	30.6	0	.	p	.	0	T127A	NONSYN	379	381	ACT	667	669	GCT	18;18;18	G;C;T	18;18;18	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2372	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4148	30.6	0	.	p	.	0	N133D	NONSYN	397	399	AAT	685	687	GAT	20;20;19	G;A;T	20;20;19	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2372	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4148	30.6	0	.	p	.	0	P162S	NONSYN	484	486	CCA	772	774	TCA	19;19;20	T;C;A	19;19;20	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2372	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4148	30.6	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	901	903	CAG	19;19;22	C;A;G	19;19;22	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2372	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4148	30.6	0	.	p	.	0	I251V	NONSYN	751	753	ATT	1039	1041	GTT	24;23;23	G;T;T	24;21;23	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2372	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4148	30.6	0	.	p	.	0	N303D	NONSYN	907	909	AAT	1195	1197	GAT	13;14;14	G;A;T	13;13;14	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2372	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4148	30.6	0	.	p	.	0	S359N	NONSYN	1075	1077	AGC	1363	1365	AAT	22;22;22	A;A;T	22;22;22	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2372	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4148	30.6	0	.	p	.	0	I366L	NONSYN	1096	1098	ATA	1384	1386	TTA	12;12;12	T;T;A	12;12;12	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2372	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4148	30.6	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	1585	1587	AAA	24;24;25	A;A;A	24;24;25	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2372	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4148	30.6	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	2320	2322	CAT	21;22;22	C;A;T	21;22;22	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2372	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4148	30.6	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	2374	2376	CAT	26;26;27	C;A;T	26;26;27	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2372	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4148	30.6	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	2392	2394	AGA	31;31;32	A;G;A	30;30;31	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2372	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4148	30.6	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	2407	2409	AAT	31;30;30	A;A;T	31;30;30	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2372	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4148	30.6	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	2554	2556	TCC	22;22;24	T;C;C	20;21;23	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2372	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4148	30.6	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	2719	2721	ATT	27;26;26	A;T;T	27;26;26	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2372	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4148	30.6	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	2740	2742	GAT	37;36;38	G;A,G;T	37;35,1;38	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2372	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4148	30.6	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	2854	2856	GTT	28;26;23	G;T;T	28;26;23	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2372	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4148	30.6	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	3139	3141	CAC	48;48;47	C;A;C	48;48;46	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	758	folP_1	849	849	99.29	folP_1.l6.c30.ctg.1	1326	30.5	1	SNP	p	P64L	0	.	.	190	192	CCA	427	429	CCA	57;56;59	C;C;A	57;56;53	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	758	folP_1	849	849	99.29	folP_1.l6.c30.ctg.1	1326	30.5	1	SNP	p	P64H	0	.	.	190	192	CCA	427	429	CCA	57;56;59	C;C;A	57;56;53	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	758	folP_1	849	849	99.29	folP_1.l6.c30.ctg.1	1326	30.5	1	SNP	p	P64A	0	.	.	190	192	CCA	427	429	CCA	57;56;59	C;C;A	57;56;53	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	758	folP_1	849	849	99.29	folP_1.l6.c30.ctg.1	1326	30.5	1	SNP	p	P64S	0	.	.	190	192	CCA	427	429	CCA	57;56;59	C;C;A	57;56;53	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	758	folP_1	849	849	99.29	folP_1.l6.c30.ctg.1	1326	30.5	1	SNP	p	P64R	0	.	.	190	192	CCA	427	429	CCA	57;56;59	C;C;A	57;56;53	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	620	gadE	528	528	100.0	gadE.l15.c30.ctg.1	1154	28.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.;gadE
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	120	gadW	729	438	94.75	gadW.l15.c4.ctg.1	531	10.9	0	.	p	.	0	D100E	NONSYN	298	300	GAC	8	10	GAA	1;1;1	G;A;A	1;1;1	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	120	gadW	729	438	94.75	gadW.l15.c4.ctg.1	531	10.9	0	.	p	.	0	P101S	NONSYN	301	303	CCC	11	13	TCC	1;1;1	T;C;C	1;1;1	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	120	gadW	729	438	94.75	gadW.l15.c4.ctg.1	531	10.9	0	.	p	.	0	R102G	NONSYN	304	306	CGG	14	16	GGG	1;1;1	G;G;G	1;1;1	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	120	gadW	729	438	94.75	gadW.l15.c4.ctg.1	531	10.9	0	.	p	.	0	K110N	NONSYN	328	330	AAA	38	40	AAT	4;4;4	A;A;T	4;4;4	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	120	gadW	729	438	94.75	gadW.l15.c4.ctg.1	531	10.9	0	.	p	.	0	S234A	NONSYN	700	702	TCG	410	412	GCG	7;7;7	G;C;G	7;7;7	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	120	gadW	729	169	93.49	gadW.l15.c4.ctg.2	169	3.8	0	.	p	.	0	L46P	NONSYN	136	138	CTG	17	19	CCG	2;2;2	C;C;G	2;2;2	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	120	gadW	729	169	93.49	gadW.l15.c4.ctg.2	169	3.8	0	.	p	.	0	E54D	NONSYN	160	162	GAA	41	43	GAT	7;7;7	G;A;T	7;7;7	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	120	gadW	729	169	93.49	gadW.l15.c4.ctg.2	169	3.8	0	.	p	.	0	I88M	NONSYN	262	264	ATA	143	145	ATG	2;2;2	A;T;G	2;2;2	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	120	gadW	729	169	93.49	gadW.l15.c4.ctg.2	169	3.8	0	.	p	.	0	Q89P	NONSYN	265	267	CAG	146	148	CCG	2;2;2	C;C;G	2;2;2	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	666	gadX	825	825	97.94	gadX.l6.c30.ctg.1	1360	26.3	0	.	p	.	0	F53L	NONSYN	157	159	TTC	431	433	TTA	28;27;28	T;T;A	28;27;28	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	666	gadX	825	825	97.94	gadX.l6.c30.ctg.1	1360	26.3	0	.	p	.	0	V79I	NONSYN	235	237	GTT	509	511	ATT	32;33;32	A;T;T	32;33;32	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	666	gadX	825	825	97.94	gadX.l6.c30.ctg.1	1360	26.3	0	.	p	.	0	R246G	NONSYN	736	738	AGA	1010	1012	GGA	18;18;17	G;G;A	18;17;17	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	666	gadX	825	825	97.94	gadX.l6.c30.ctg.1	1360	26.3	0	.	p	.	0	S248P	NONSYN	742	744	TCG	1016	1018	CCG	16;17;16	C;C;G	16;17;16	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2282	gyrA_7	2628	2628	98.67	gyrA_7.l15.c30.ctg.1	3215	38.0	1	SNP	p	S83L	1	S83L	NONSYN	247	249	TCG	547	549	TTG	37;37;37	T;T;G	37;35;37	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2282	gyrA_7	2628	2628	98.67	gyrA_7.l15.c30.ctg.1	3215	38.0	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2332	2334	GAA	40;40;40	G;A;A	40;40;40	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2282	gyrA_7	2628	2628	98.67	gyrA_7.l15.c30.ctg.1	3215	38.0	1	SNP	p	D87V	0	.	.	259	261	GAC	559	561	GAC	41;42;45	G;A;C	41;41;45	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2282	gyrA_7	2628	2628	98.67	gyrA_7.l15.c30.ctg.1	3215	38.0	1	SNP	p	D87G	0	.	.	259	261	GAC	559	561	GAC	41;42;45	G;A;C	41;41;45	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2282	gyrA_7	2628	2628	98.67	gyrA_7.l15.c30.ctg.1	3215	38.0	1	SNP	p	D87Y	0	.	.	259	261	GAC	559	561	GAC	41;42;45	G;A;C	41;41;45	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2282	gyrA_7	2628	2628	98.67	gyrA_7.l15.c30.ctg.1	3215	38.0	1	SNP	p	D87N	0	.	.	259	261	GAC	559	561	GAC	41;42;45	G;A;C	41;41;45	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2282	gyrA_7	2628	2628	98.67	gyrA_7.l15.c30.ctg.1	3215	38.0	1	SNP	p	D87H	0	.	.	259	261	GAC	559	561	GAC	41;42;45	G;A;C	41;41;45	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2122	gyrB_1	2415	2415	99.05	gyrB_1.l6.c30.ctg.1	3004	37.9	1	SNP	p	R136I	0	.	.	406	408	CGC	746	748	CGC	46;49;49	C;G;C	46;49;49	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2122	gyrB_1	2415	2415	99.05	gyrB_1.l6.c30.ctg.1	3004	37.9	1	SNP	p	R136H	0	.	.	406	408	CGC	746	748	CGC	46;49;49	C;G;C	46;49;49	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2122	gyrB_1	2415	2415	99.05	gyrB_1.l6.c30.ctg.1	3004	37.9	1	SNP	p	R136E	0	.	.	406	408	CGC	746	748	CGC	46;49;49	C;G;C	46;49;49	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2122	gyrB_1	2415	2415	99.05	gyrB_1.l6.c30.ctg.1	3004	37.9	1	SNP	p	R136C	0	.	.	406	408	CGC	746	748	CGC	46;49;49	C;G;C	46;49;49	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2122	gyrB_1	2415	2415	99.05	gyrB_1.l6.c30.ctg.1	3004	37.9	1	SNP	p	R136L	0	.	.	406	408	CGC	746	748	CGC	46;49;49	C;G;C	46;49;49	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2122	gyrB_1	2415	2415	99.05	gyrB_1.l6.c30.ctg.1	3004	37.9	1	SNP	p	R136G	0	.	.	406	408	CGC	746	748	CGC	46;49;49	C;G;C	46;49;49	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2122	gyrB_1	2415	2415	99.05	gyrB_1.l6.c30.ctg.1	3004	37.9	1	SNP	p	R136S	0	.	.	406	408	CGC	746	748	CGC	46;49;49	C;G;C	46;49;49	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	494	kdpE	678	678	98.23	kdpE.l15.c30.ctg.1	1153	22.5	0	.	p	.	0	A72P	NONSYN	214	216	GCG	493	495	CCG	28;28;30	C;C;G	28;28;30	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	494	kdpE	678	678	98.23	kdpE.l15.c30.ctg.1	1153	22.5	0	.	p	.	0	T123A	NONSYN	367	369	ACC	646	648	GCC	19;18;19	G;C;C	18;18;19	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	826	leuO	945	945	99.26	leuO.l6.c30.ctg.1	1416	31.0	0	.	p	.	0	P9S	NONSYN	25	27	CCA	280	282	TCA	14;14;15	T;C;A	14;14;15	.	leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.;leuO
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	332	marA	384	384	99.74	marA.l15.c4.ctg.1	932	19.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.;marA
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	216	marR	435	435	97.7	marR.l15.c4.ctg.1	875	13.0	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	545	547	AGC	14;15;16	A;G;C	14;15;15	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	216	marR	435	435	97.7	marR.l15.c4.ctg.1	875	13.0	1	SNP	p	Y137H	1	Y137H	NONSYN	409	411	TAT	647	649	CAT	4;4;4	C;A;T	4;4;4	marR.3003378.U00096.1619119_1619554.2097:1:1:Y137H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	216	marR	435	435	97.7	marR.l15.c4.ctg.1	875	13.0	1	SNP	p	V45E	0	.	.	133	135	GTG	371	373	GTG	22;22;23	G;T;G	21;22;22	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	216	marR	435	435	97.7	marR.l15.c4.ctg.1	875	13.0	1	SNP	p	I49S	0	.	.	145	147	ATC	383	385	ATC	25;25;22	A;T;C	25;22;22	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	216	marR	435	435	97.7	marR.l15.c4.ctg.1	875	13.0	1	SNP	p	A70T	0	.	.	208	210	GCA	446	448	GCA	21;21;22	G;C;A	21;21;22	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	216	marR	435	435	97.7	marR.l15.c4.ctg.1	875	13.0	1	SNP	p	R73S	0	.	.	217	219	CGT	455	457	CGT	21;21;20	C;G;T	21;21;20	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	216	marR	435	435	97.7	marR.l15.c4.ctg.1	875	13.0	1	SNP	p	R73C	0	.	.	217	219	CGT	455	457	CGT	21;21;20	C;G;T	21;21;20	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	216	marR	435	435	97.7	marR.l15.c4.ctg.1	875	13.0	1	SNP	p	R77C	0	.	.	229	231	CGC	467	469	CGC	20;20;20	C;G;C	20;20;20	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	216	marR	435	435	97.7	marR.l15.c4.ctg.1	875	13.0	1	SNP	p	R77L	0	.	.	229	231	CGC	467	469	CGC	20;20;20	C;G;C	20;20;20	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	216	marR	435	435	97.7	marR.l15.c4.ctg.1	875	13.0	1	SNP	p	L78M	0	.	.	232	234	CTG	470	472	CTG	19;19;19	C;T;G	19;19;19	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	216	marR	435	435	97.7	marR.l15.c4.ctg.1	875	13.0	1	SNP	p	R94H	0	.	.	280	282	CGC	518	520	CGC	16;17;17	C;G;C	16;17;17	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	216	marR	435	435	97.7	marR.l15.c4.ctg.1	875	13.0	1	SNP	p	R94S	0	.	.	280	282	CGC	518	520	CGC	16;17;17	C;G;C	16;17;17	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	216	marR	435	435	97.7	marR.l15.c4.ctg.1	875	13.0	1	SNP	p	V96E	0	.	.	286	288	GTA	524	526	GTA	18;17;17	G;T;A	18;17;17	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	674	mdfA	1233	1233	97.0	mdfA.l6.c4.ctg.1	1664	21.5	0	.	p	.	0	S7F	NONSYN	19	21	TCC	224	226	TTC	3;3;3	T;T;C	3;3;3	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	674	mdfA	1233	1233	97.0	mdfA.l6.c4.ctg.1	1664	21.5	0	.	p	.	0	R36I	NONSYN	106	108	AGG	311	313	ATC	15;14;14	A;T;C	15;14;14	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	674	mdfA	1233	1233	97.0	mdfA.l6.c4.ctg.1	1664	21.5	0	.	p	.	0	E42A	NONSYN	124	126	GAA	329	331	GCC	8;9;9	G;C;C	8;9;9	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	674	mdfA	1233	1233	97.0	mdfA.l6.c4.ctg.1	1664	21.5	0	.	p	.	0	N43V	NONSYN	127	129	AAT	332	334	GTG	9;9;9	G;T;G	9;9;9	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	674	mdfA	1233	1233	97.0	mdfA.l6.c4.ctg.1	1664	21.5	0	.	p	.	0	E52D	NONSYN	154	156	GAG	359	361	GAT	11;10;10	G;A;T	10;9;9	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	674	mdfA	1233	1233	97.0	mdfA.l6.c4.ctg.1	1664	21.5	0	.	p	.	0	N59T	NONSYN	175	177	AAC	380	382	ACC	11;11;11	A;C;C,T	11;11;10,1	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	674	mdfA	1233	1233	97.0	mdfA.l6.c4.ctg.1	1664	21.5	0	.	p	.	0	I68L	NONSYN	202	204	ATA	407	409	TTA	12;11;10	T;T;A	12;11;10	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	674	mdfA	1233	1233	97.0	mdfA.l6.c4.ctg.1	1664	21.5	0	.	p	.	0	H115Q	NONSYN	343	345	CAC	548	550	CAG	44;43;43	C;A;G	44;43;43	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	674	mdfA	1233	1233	97.0	mdfA.l6.c4.ctg.1	1664	21.5	0	.	p	.	0	D128A	NONSYN	382	384	GAC	587	589	GCC	35;35;35	G;C;C	35;35;35	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	674	mdfA	1233	1233	97.0	mdfA.l6.c4.ctg.1	1664	21.5	0	.	p	.	0	S163A	NONSYN	487	489	TCG	692	694	GCG	26;26;29	G;C;G	26;26;28	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	674	mdfA	1233	1233	97.0	mdfA.l6.c4.ctg.1	1664	21.5	0	.	p	.	0	L231V	NONSYN	691	693	CTT	896	898	GTT	18;18;18	G;T;T	14;15;18	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	674	mdfA	1233	1233	97.0	mdfA.l6.c4.ctg.1	1664	21.5	0	.	p	.	0	R285fs	FSHIFT	853	853	C	1058	1058	C	34	C	34	.	mdfA;Multidrug translocase MdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	756	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1630	24.7	0	.	p	.	0	V12trunc	TRUNC	34	34	G	226	226	G	21	G	21	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	756	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1630	24.7	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	283	285	CAG	25;23;23	C;A;G	25;23;23	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	756	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1630	24.7	0	.	p	.	0	T83I	NONSYN	247	249	ACC	433	435	ATC	20;20;18	A;T;C	20;20;17	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	756	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1630	24.7	0	.	p	.	0	I99M	NONSYN	295	297	ATA	481	483	ATG	13;13;13	A;T;G	13;13;13	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	756	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1630	24.7	0	.	p	.	0	A130T	NONSYN	388	390	GCC	574	576	ACC	26;26;25	A;C;C	25;25;25	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	756	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1630	24.7	0	.	p	.	0	P257T	NONSYN	769	771	CCG	955	957	ACG	32;31;32	A;C;G	32;31;32	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2124	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3545	32.2	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	1969	1971	ACC	37;38;39	A;C;C	37;38;38	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2124	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3545	32.2	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2362	2364	CAA	39;40;38	C;A;A	39;38;38	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2124	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3545	32.2	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2530	2532	ATT	33;32;32	A;T;T	33;32;32	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2124	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3545	32.2	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2614	2616	GTT	26;25;27	G;T;T	25;24;27	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2124	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3545	32.2	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2722	2724	GAG	19;19;20	G;A;G	19;19;20	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2124	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3545	32.2	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	2950	2952	ATG	18;19;20	A;T;G	18;19;20	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2124	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3545	32.2	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3085	3087	GAT	29;29;32	G;A;T	29;28;31	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2036	mdtC	3078	3078	98.64	mdtC.l15.c4.ctg.1	3605	30.2	0	.	p	.	0	I46M	NONSYN	136	138	ATC	328	330	ATG	20;20;21	A;T;G	20;19;19	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2036	mdtC	3078	3078	98.64	mdtC.l15.c4.ctg.1	3605	30.2	0	.	p	.	0	V208I	NONSYN	622	624	GTC	814	816	ATC	43;42;42	A;T;C	43;42;42	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2036	mdtC	3078	3078	98.64	mdtC.l15.c4.ctg.1	3605	30.2	0	.	p	.	0	Q980H	NONSYN	2938	2940	CAA	3130	3132	CAC	17;17;17	C;A;C	17;16;16	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2036	mdtC	3078	3078	98.64	mdtC.l15.c4.ctg.1	3605	30.2	0	.	p	.	0	P981L	NONSYN	2941	2943	CCC	3133	3135	CTC	17;17;17	C;T;C	17;17;17	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1046	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1960	28.7	0	.	p	.	0	D3E	NONSYN	7	9	GAT	259	261	GAA	27;30;31	G;A;A	27;29;31	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1046	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1960	28.7	0	.	p	.	0	T226A	NONSYN	676	678	ACG	928	930	GCG	40;40;41	G;C;G	40;40;41	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1046	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1960	28.7	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1270	1272	ATC	34;33;34	A;T;C	34;33;34	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1046	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1960	28.7	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1573	1575	TTT	34;35;36	T;T;T	34;34;36	.	mdtD;Efflux pump mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	1088	mdtE	1158	1158	99.31	mdtE.l15.c30.ctg.1	1823	32.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdtE;MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	2882	mdtF	3114	3114	98.52	mdtF.l15.c30.ctg.1	3706	41.7	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1223	1225	ACC	41;41;39	A;C;C	41;40;39	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	2882	mdtF	3114	3114	98.52	mdtF.l15.c30.ctg.1	3706	41.7	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2465	2467	GAC	35;35;35	G;A;C	35;35;35	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	976	mdtG	1227	1047	99.33	mdtG.l6.c30.ctg.1	1565	27.4	0	.	p	.	0	V200I	NONSYN	598	600	GTC	620	622	ATC	45;44;45	A;T;C	45;42;45	.	mdtG;Efflux protien mdtG.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	976	mdtG	1227	182	99.45	mdtG.l6.c30.ctg.2	563	16.5	0	.	p	.	0	E5G	NONSYN	13	15	GAA	156	158	GGA	18;17;17	G;G;A	18;17;17	.	mdtG;Efflux protien mdtG.
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	764	mdtH	1209	1209	98.18	mdtH.l6.c30.ctg.1	1572	25.9	0	.	p	.	0	G134C	NONSYN	400	402	GGT	604	606	TGT	38;37;37	T;G;T	38;37;37	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	764	mdtH	1209	1209	98.18	mdtH.l6.c30.ctg.1	1572	25.9	0	.	p	.	0	S324L	NONSYN	970	972	TCG	1174	1176	TTG	31;32;33	T;T;G	31;31;33	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	764	mdtH	1209	1209	98.18	mdtH.l6.c30.ctg.1	1572	25.9	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1384	1386	ACG	8;8;8	A;C;G	8;8;8	.	Multidrug resistance protein MdtH;mdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	1070	mdtL	1176	1176	98.38	mdtL.l6.c17.ctg.1	1841	31.3	0	.	p	.	0	A185S	NONSYN	553	555	GCC	912	914	TCC	28;27;27	T;C;C	28;27;27	.	mdtL;Multidrug resistance protein MdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	884	mdtN	1032	1032	98.06	mdtN.l15.c4.ctg.1	1618	29.2	0	.	p	.	0	V119I	NONSYN	355	357	GTT	630	632	ATT	22;22;24	A;T;T	21;22;24	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.;mdtN
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1628	mdtO	2052	2052	98.1	mdtO.l6.c4.ctg.1	2533	34.4	0	.	p	.	0	V11M	NONSYN	31	33	GTG	271	273	ATG	29;31;32	A;T;G	29;31;32	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1628	mdtO	2052	2052	98.1	mdtO.l6.c4.ctg.1	2533	34.4	0	.	p	.	0	T33I	NONSYN	97	99	ACC	337	339	ATC	24;23;21	A;T;C	21;19;19	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1628	mdtO	2052	2052	98.1	mdtO.l6.c4.ctg.1	2533	34.4	0	.	p	.	0	C116R	NONSYN	346	348	TGC	586	588	CGC	46;43;41	C;G;C	46;43;41	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1628	mdtO	2052	2052	98.1	mdtO.l6.c4.ctg.1	2533	34.4	0	.	p	.	0	N238S	NONSYN	712	714	AAC	952	954	AGC	26;25;25	A;G;C	25;25;25	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1628	mdtO	2052	2052	98.1	mdtO.l6.c4.ctg.1	2533	34.4	0	.	p	.	0	M305V	NONSYN	913	915	ATG	1153	1155	GTG	42;42;42	G;T;G	41;38;42	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1628	mdtO	2052	2052	98.1	mdtO.l6.c4.ctg.1	2533	34.4	0	.	p	.	0	D326N	NONSYN	976	978	GAC	1216	1218	AAC	19;18;18	A;A,C;C	17;16,1;17	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1628	mdtO	2052	2052	98.1	mdtO.l6.c4.ctg.1	2533	34.4	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	1261	1263	GTC	34;34;34	G;T;C	34;34;34	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1628	mdtO	2052	2052	98.1	mdtO.l6.c4.ctg.1	2533	34.4	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	1291	1293	ATA	41;40;41	A;T;A	41;40;40	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1628	mdtO	2052	2052	98.1	mdtO.l6.c4.ctg.1	2533	34.4	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	1399	1401	TCT	27;28;31	T;C;T	27;28;31	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1628	mdtO	2052	2052	98.1	mdtO.l6.c4.ctg.1	2533	34.4	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	1786	1788	GCG	35;36;37	G;C;G	35;33;37	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1628	mdtO	2052	2052	98.1	mdtO.l6.c4.ctg.1	2533	34.4	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	1999	2001	ATC	53;52;52	A;T;C	52;52;50	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1072	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1955	29.5	0	.	p	.	0	S129A	NONSYN	385	387	TCA	617	619	GCG	29;27;26	G;C;G	29;27;26	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1072	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1955	29.5	0	.	p	.	0	A187T	NONSYN	559	561	GCC	791	793	ACC	40;41;39	A;C;C	40;40;39	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1072	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1955	29.5	0	.	p	.	0	H211R	NONSYN	631	633	CAC	863	865	CGC	34;34;33	C;G;C	34;34;33	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1072	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1955	29.5	0	.	p	.	0	V250A	NONSYN	748	750	GTT	980	982	GCT	27;28;32	G;C;T	27;28;31	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1072	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1955	29.5	0	.	p	.	0	R278K	NONSYN	832	834	AGA	1064	1066	AAA	24;25;27	A;A;A	24;25;27	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1072	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1955	29.5	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	1082	1084	CGA	35;35;35	C;G;A	34;34;34	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1072	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1955	29.5	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1247	1249	GCC	39;42;41	G;C;C	39;42;41	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1072	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1955	29.5	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1259	1261	GAT	41;41;41	G;A;T	41;40;41	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1072	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1955	29.5	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1676	1678	GCT	16;15;15	G;C;T	16;15;15	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	2402	mfd	3447	3447	99.13	mfd.l15.c4.ctg.1	3846	33.4	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1489	1491	AAG	32;32;32	A;A;G	32;31;32	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	2402	mfd	3447	3447	99.13	mfd.l15.c4.ctg.1	3846	33.4	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2566	2568	CTG	30;32;32	C;T;G	30;31;32	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	27	134	mgrB	144	144	100.0	mgrB.l15.c30.ctg.1	579	11.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB;mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1398	msbA	1749	1749	98.68	msbA.l15.c30.ctg.1	2281	32.8	0	.	p	.	0	S278N	NONSYN	832	834	AGC	1043	1045	AAC	31;30;33	A;A;C	31;30;31	.	msbA;MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1398	msbA	1749	1749	98.68	msbA.l15.c30.ctg.1	2281	32.8	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1589	1591	ATA	48;49;48	A;T;A	48;49;48	.	msbA;MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	1110	murA_12	1260	1260	98.49	murA_12.l15.c4.ctg.1	1767	33.7	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1340	1342	GAT	63;61;60	G;A;T	63;61;60	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	1110	murA_12	1260	1260	98.49	murA_12.l15.c4.ctg.1	1767	33.7	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1343	1345	CTG	57;56;56	C;T;G	57;56;56	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	554	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1117	26.2	0	.	p	.	0	R27C	NONSYN	79	81	CGT	258	260	TGT	23;21;21	T;G;T	22;21;20	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	554	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1117	26.2	0	.	p	.	0	I117T	NONSYN	349	351	ATC	528	530	ACC	32;33;33	A;C;C	31;33;33	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	554	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1117	26.2	0	.	p	.	0	G187D	NONSYN	559	561	GGC	738	740	GAC	49;45;43	G;A;C	49;45;43	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	554	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1117	26.2	1	SNP	p	R15C	0	.	.	43	45	CGC	222	224	CGC	40;37;36	C;G;C	40;37;36	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	554	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1117	26.2	1	SNP	p	S33R	0	.	.	97	99	AGC	276	278	AGC	23;24;24	A;G;C	23;24;24	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	554	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1117	26.2	1	SNP	p	G131D	0	.	.	391	393	GGC	570	572	GGC	31;29;30	G;G;C	30;28;27	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	554	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1117	26.2	1	SNP	p	R203L	0	.	.	607	609	CGT	786	788	CGT	35;36;35	C;G;T	35;36;35	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203L:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	554	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1117	26.2	1	SNP	p	R203C	0	.	.	607	609	CGT	786	788	CGT	35;36;35	C;G;T	35;36;35	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	978	ompF	1089	1089	99.91	ompF.l6.c30.ctg.1	1575	33.0	0	.	p	.	0	D312E	NONSYN	934	936	GAT	1188	1190	GAG	43;45;44	G;A;G	43;45;44	.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	978	ompF	1089	1089	99.91	ompF.l6.c30.ctg.1	1575	33.0	1	SNP	p	G141D	0	.	.	421	423	GGT	675	677	GGT	44;43;43	G;G;T	43;43;41	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	978	ompF	1089	1089	99.91	ompF.l6.c30.ctg.1	1575	33.0	1	SNP	p	G141E	0	.	.	421	423	GGT	675	677	GGT	44;43;43	G;G;T	43;43;41	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	978	ompF	1089	1089	99.91	ompF.l6.c30.ctg.1	1575	33.0	1	SNP	p	R154D	0	.	.	460	462	CGT	714	716	CGT	57;58;57	C;G;T	57;58;57	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	978	ompF	1089	1089	99.91	ompF.l6.c30.ctg.1	1575	33.0	1	SNP	p	R154A	0	.	.	460	462	CGT	714	716	CGT	57;58;57	C;G;T	57;58;57	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2152	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2835	40.7	0	.	p	.	0	A533V	NONSYN	1597	1599	GCG	1880	1882	GTG	52;52;55	G;T;G	51;52;55	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2152	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2835	40.7	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1907	1909	TCG	60;59;57	T;C;G	55;56;56	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2152	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2835	40.7	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2522	2524	AAC	32;32;32	A;A;C	32;31;32	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2152	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2835	40.7	1	SNP	p	A85T	0	.	.	253	255	GCG	536	538	GCG	44;44;45	G;C;G	41;41;42	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2152	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2835	40.7	1	SNP	p	D111H	0	.	.	331	333	GAT	614	616	GAT	43;44;42	G;A;T	43;44;42	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2152	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2835	40.7	1	SNP	p	S129P	0	.	.	385	387	TCC	668	670	TCC	43;42;43	T;C;C	42;42;43	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	1394	parE_1	1893	1893	97.52	parE_1.l6.c30.ctg.1	2442	30.5	0	.	p	.	0	D473N	NONSYN	1417	1419	GAC	1647	1649	AAC	39;42;43	A;A;C	39;42;43	.	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	1394	parE_1	1893	1893	97.52	parE_1.l6.c30.ctg.1	2442	30.5	1	SNP	p	D476N	0	.	.	1426	1428	GAT	1656	1658	GAT	44;44;43	G;A;T	44;43;43	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	1330	patA	1380	1380	99.78	patA.l15.c4.ctg.1	1949	36.5	0	.	p	.	0	P202Q	NONSYN	604	606	CCG	924	926	CAG	53;54;55	C;A;G	53;53;55	.	PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.;patA
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	1330	patA	1380	1380	99.78	patA.l15.c4.ctg.1	1949	36.5	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1398	1400	GAT	33;34;33	G;A;T	33;33;32	.	PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.;patA
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3890	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4553	45.9	1	SNP	p	V146F	0	.	.	436	438	GTT	681	683	GTT	43;42;42	G;T;T	43;41;42	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3890	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4553	45.9	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1782	1784	CAG	52;53;53	C;A;G	51;53;53	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3890	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4553	45.9	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1782	1784	CAG	52;53;53	C;A;G	51;53;53	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3890	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4553	45.9	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1821	1823	CAC	43;42;42	C;A;C	43;42;42	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3890	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4553	45.9	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1830	1832	CGT	39;37;37	C;G;T	39;37;36	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3890	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4553	45.9	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1830	1832	CGT	39;37;37	C;G;T	39;37;36	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3890	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4553	45.9	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1836	1838	TCC	41;42;42	T;C;C,T	41;42;41,1	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3890	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4553	45.9	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1842	1844	CTC	41;38;39	C;T;C	41;38;39	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3890	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4553	45.9	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1932	1934	ACC	53;53;53	A;C;C	53;53;53	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3890	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4553	45.9	1	SNP	p	P564L	0	.	.	1690	1692	CCT	1935	1937	CCT	51;51;52	C;C;T,G	51;51;51,1	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3890	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4553	45.9	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2304	2306	CGT	53;52;50	C;G;T	53;52;49	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11200	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.1	1026	343.1	0	.	n	.	0	A226G	SNP	226	226	A	251	251	G	349	G	349	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11200	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.1	1026	343.1	0	.	n	.	0	C719T	SNP	719	719	C	744	744	T	337	T,C	170,163	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11200	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.1	1026	343.1	1	SNP	n	A794G	0	.	.	794	794	A	819	819	A	348	A,C	340,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11200	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.1	1026	343.1	1	SNP	n	A794T	0	.	.	794	794	A	819	819	A	348	A,C	340,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11200	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.1	1026	343.1	1	SNP	n	G926T	0	.	.	926	926	G	951	951	G	325	G	323	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11200	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.1	1026	343.1	1	SNP	n	G926A	0	.	.	926	926	G	951	951	G	325	G	323	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11200	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.1	1026	343.1	1	SNP	n	G926C	0	.	.	926	926	G	951	951	G	325	G	323	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11200	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.1	1026	343.1	0	HET	.	.	.	A79G	.	79	79	A	104	104	A	336	A,G	246,86	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11200	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.1	1026	343.1	0	HET	.	.	.	T273A	.	273	273	T	298	298	T	354	T,A	266,85	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11200	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.1	1026	343.1	0	HET	.	.	.	C183T	.	183	183	C	208	208	C	315	C,T	211,99	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11200	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.1	1026	343.1	0	HET	.	.	.	A250T	.	250	250	A	275	275	A	321	A,T	244,74	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11200	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.1	1026	343.1	0	HET	.	.	.	T90C	.	90	90	T	115	115	T	364	T,C	265,95	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11200	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.1	1026	343.1	0	HET	.	.	.	G474A,T	.	474	474	G	499	499	G	341	G,A,T	258,78,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11200	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.1	1026	343.1	0	HET	.	.	.	A253T	.	253	253	A	278	278	A	327	A,T	246,75	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11200	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.1	1026	343.1	0	HET	.	.	.	C194T	.	194	194	C	219	219	C	317	C,T	256,59	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11200	rrsB+	1542	504	100.0	rrsB+.l15.c30.ctg.2	518	326.7	1	SNP	n	A1519G	0	.	.	1519	1519	A	481	481	A	233	A	232	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11200	rrsB+	1542	504	100.0	rrsB+.l15.c30.ctg.2	518	326.7	1	SNP	n	A1519C	0	.	.	1519	1519	A	481	481	A	233	A	232	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11200	rrsB+	1542	504	100.0	rrsB+.l15.c30.ctg.2	518	326.7	1	SNP	n	A1519T	0	.	.	1519	1519	A	481	481	A	233	A	232	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11200	rrsB+	1542	141	100.0	rrsB+.l15.c30.ctg.5	141	88.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11200	rrsB+	1542	142	95.1	rrsB+.l15.c30.ctg.6	142	89.9	0	.	n	.	0	G1002A	SNP	1002	1002	G	53	53	A	124	A	124	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11200	rrsB+	1542	142	95.1	rrsB+.l15.c30.ctg.6	142	89.9	0	.	n	.	0	G1006C	SNP	1006	1006	G	57	57	C	130	C	130	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11200	rrsB+	1542	142	95.1	rrsB+.l15.c30.ctg.6	142	89.9	0	.	n	.	0	T1010C	SNP	1010	1010	T	61	61	C	130	C	128	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11200	rrsB+	1542	142	95.1	rrsB+.l15.c30.ctg.6	142	89.9	0	.	n	.	0	A1019.	DEL	1019	1019	A	69	69	G	132	G	132	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11200	rrsB+	1542	142	95.1	rrsB+.l15.c30.ctg.6	142	89.9	0	.	n	.	0	.1023G	INS	1023	1023	T	74	74	G	122	G	122	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	11200	rrsB+	1542	142	95.1	rrsB+.l15.c30.ctg.6	142	89.9	0	.	n	.	0	C1038T	SNP	1038	1038	C	89	89	T	114	T	113	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
sat_1.3002895.AB211124.0_525.584	sat_1.3002895.AB211124.0_525.584	1	0	27	654	sat_1	525	525	100.0	sat_1.l15.c30.ctg.1	1119	31.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	sat-1 is a plasmid-mediated streptothricin acetyltransferase in Escherichia coli;sat-1
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	552	soxR	465	465	100.0	soxR.l6.c4.ctg.1	1084	27.4	1	SNP	p	R20H	0	.	.	58	60	CGC	380	382	CGC	51;49;53	C;G;C	51;49;53	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	552	soxR	465	465	100.0	soxR.l6.c4.ctg.1	1084	27.4	1	SNP	p	G121D	0	.	.	361	363	GGT	683	685	GGT	48;50;50	G;G;T	48;50;50	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	394	soxS_1	324	324	99.69	soxS_1.l15.c30.ctg.1	928	22.6	1	SNP	p	A12S	0	.	.	34	36	GCA	322	324	GCA	42;45;44	G;C;A	42;45;44	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
strA.manually_added_NC_009345_WP_001082319.1_6656_7459	strA.manually_added_NC_009345_WP_001082319.1_6656_7459	1	0	27	1652	APH_3____Ib+	804	804	100.0	APH_3____Ib+.l15.c17.ctg.1	1359	64.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
strB.manually_added_NC_009345_WP_000480968.1_7459_8295	strB.manually_added_NC_009345_WP_000480968.1_7459_8295	1	0	27	2038	APH_6__Id+	837	837	100.0	APH_6__Id+.l15.c30.ctg.1	1425	75.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
sul1.manually_added_NC_002134_NP_052895.3_12192_13058	sul1.manually_added_NC_002134_NP_052895.3_12192_13058	1	0	27	282	sul1	867	867	100.0	sul1.l6.c4.ctg.1	1221	12.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_002134.1 Shigella flexneri 2b plasmid R100 DNA, complete sequence
sul2.manually_added_NC_009345_WP_001043267.1_5780_6595	sul2.manually_added_NC_009345_WP_001043267.1_5780_6595	1	0	27	1292	sul2	816	816	100.0	sul2.l15.c30.ctg.1	1398	49.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tetA.manually_added_NC_009345_WP_000804063.1_1230_2429	tetA.manually_added_NC_009345_WP_000804063.1_1230_2429	1	0	27	1888	tetA	1200	1200	100.0	tetA.l6.c30.ctg.1	1806	55.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tetR.manually_added_NC_009345_WP_000164043.1_474_1124	tetR.manually_added_NC_009345_WP_000164043.1_474_1124	1	0	27	1096	tetR	651	651	100.0	tetR.l15.c4.ctg.1	1194	49.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	1348	tolC	1488	1488	98.72	tolC.l15.c30.ctg.1	1990	36.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.;tolC
